Comparison of rivaroxaban and dalteparin for the long-term treatment of venous thromboembolism in patients with gynecologic cancers

OBJECTIVES: Two randomized, controlled studies comparing outcomes in patients treated with direct oral anticoagulants or low-molecular weight heparin for cancer-associated venous thromboembolism (VTE) have previously been performed. However, gynecologic cancers accounted for approximately 10% of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jang Ho, Lee, Joo Hee, Jo, Kyung-Wook, Huh, Jin-Won, Oh, Yeon-Mok, Lee, Jae Seung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918888/
https://www.ncbi.nlm.nih.gov/pubmed/31789000
http://dx.doi.org/10.3802/jgo.2020.31.e10

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6918888/
https://www.ncbi.nlm.nih.gov/pubmed/31789000
http://dx.doi.org/10.3802/jgo.2020.31.e10

Ejemplares similares